Clinical Trial Update: Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing measurement of risperidone treatment outcomes in persons with Borderline Personality Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Borderline Personality Disorder | Phase 4 | Status: COMPLETED